36901-99-2 Usage
Uses
Used in Pharmaceutical Industry:
CEPC is utilized as a key intermediate in the synthesis of various pharmaceuticals due to its ability to participate in a wide range of chemical reactions. Its unique structure and functional groups contribute to the development of new molecules and drugs, making it an indispensable component in medicinal chemistry.
Used in Organic Synthesis:
As a reagent in organic synthesis, CEPC is employed for its versatility and stability. It serves as a valuable building block in the preparation of a diverse array of bioactive compounds, facilitating advancements in chemical research and the creation of innovative chemical entities.
Used in Research and Development:
CEPC is also used in research and development settings to explore its potential applications and reactions. Its unique properties make it a promising candidate for the discovery of new chemical pathways and the synthesis of novel compounds with potential applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 36901-99-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,9,0 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 36901-99:
(7*3)+(6*6)+(5*9)+(4*0)+(3*1)+(2*9)+(1*9)=132
132 % 10 = 2
So 36901-99-2 is a valid CAS Registry Number.
36901-99-2Relevant academic research and scientific papers
A Convenient On-Site Oxidation Strategy for the N -Hydroxylation of Melanostatin Neuropeptide Using Cope Elimination
Correia, Xavier Cruz,Costa-Almeida, Hugo F.,Pires-Lima, Beatriz L.,Sampaio-Dias, Ivo E.,Silva-Reis, Sara C.
, (2022/02/16)
A convenient synthetic protocol for the unprecedented N-hydroxylation of proline residue in Melanostatin (MIF-1) neuropeptide is reported. This methodology is grounded on the incorporation of N-(cyanoethyl)prolyl residue followed by on-site oxidation by Cope elimination with m-chloroperbenzoic acid, exploring the unrecognized dual role of the cyanoethyl group as an effective N-protecting group under peptide synthesis conditions and as a suitable leaving group during the chemoselective on-site N-oxidation. Following this protocol N-hydroxy-MIF-1 is obtained in 78% global yield from N-(cyanoethyl)-Lproline. This synthetic approach opens a new avenue for access to N-hydroxylated Melanostatin analogues with direct application in neurochemistry and Parkinson s research.
